Genetic Polymorphisms of Cytochrome P450 and Antidepressants

Wu-Chou, Ana Isabel; Liu, Yuli; Shen, Winston W.

doi:10.1007/978-81-322-2803-5_34

Search citation statements

Order By: Relevance

Paper Sections

Select...

Clinical Practice Of Prescribing Anticraving Drugs For Treat1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

2023

Publication Types

Select...

Article1

Book1

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 92 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All my topiramate medicated‐patients are seen weekly until they are completely sober. Then, they are given monthly prescription for topiramate, which can be combined with any concurrent antidepressants without any concerns of drug‐drug interaction . Usually, most of all my patients welcome the use of topiramate because of its superior anticraving benefit to naltrexone .…”

Section: Clinical Practice Of Prescribing Anticraving Drugs For Treatmentioning

confidence: 99%

Anticraving therapy for alcohol use disorder: A clinical review

Shen

2018

Neuropsychopharm Rep

Self Cite

View full text Add to dashboard Cite

Although slowly developing, the field of anticraving drugs is getting into shape as a promising entity of a pharmaceutical class of drugs. Then, the author addressed on the underused issues of those recommended, and suggested anticraving drugs by the practice guideline of the American Psychiatric Association. The author urges that clinicians should be more "adventurous" in prescribing those promising drugs because benefits of those anticraving drugs are far-outweighing the possible side effects of anticraving drugs, or the harms of untreated AUD itself.

show abstract

Section: Clinical Practice Of Prescribing Anticraving Drugs For Treatmentioning

confidence: 99%